Key Takeaways The mergers & acquisitions bounce investors expected after President Donald Trump’s return to the White House ...
Oppenheimer said on Wednesday it no longer expects growth in U.S. investment banking revenue this year and slashed its ...
More than a year after Warner Bros. shelved “Coyote vs. Acme” for tax incentives, the Looney Tunes-inspired film is close to ...
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
Such an advance, leaders agree, would fundamentally transform society. Google CEO Sundar Pichai has repeatedly described AI ...
He was a man of contradictions: a brilliant physicist, fuelled by self-loathing; a student of philosophy and mysticism, who longed to be an all-American hero. He was responsible for building the most ...
Christopher Nolan doesn't need an image to maintain; from Following (1998) to Oppenheimer (2023), fans know what's in store ...
Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...
Oppenheimer analyst Michael Wiederhorn is updating its Amedisys (AMED) model following the Q4 earnings release. Amedisys is currently in the ...
Oppenheimer will be released on Netflix on March 21, 2025. The movie will be made available to stream on OTT platform with a ...
Oppenheimer analyst Matthew Biegler lowered the firm’s price target on Olema Oncology (OLMA) to $25 from $30 but keeps an Outperform rating on ...